Crow, Mary K

Publications

Sort by

Co-Author Network

selected publications

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update. Annals of the rheumatic diseases. 2022 Conference Paper GET IT
Times cited: 5
Polymeric dexamethasone prodrugs attenuate lupus nephritis in MRL/lpr mice with reduced glucocorticoid toxicity. Nanomedicine : nanotechnology, biology, and medicine. 2022 Academic Article GET IT
Hydroxychloroquine and lupus flare: a good drug, but we need to do better. Annals of the rheumatic diseases. 2022 Editorial Article GET IT
When a Diagnosis Has No Name: Uncertainty and Opportunity. ACR open rheumatology. 2021 Academic Article GET IT
Times cited: 4
Preclinical Dose-Escalation Study of ZSJ-0228, a Polymeric Dexamethasone Prodrug, in the Treatment of Murine Lupus Nephritis. Molecular pharmaceutics. 2021 Academic Article GET IT
Times cited: 1
The role of immunomodulatory medications in the treatment of COVID-19. Current opinion in rheumatology. 2021 Review GET IT
Times cited: 4
Pregnancy and Rheumatic Disease: Experience at a Single Center in New York City During the COVID-19 Pandemic. Arthritis care & research. 2021 Academic Article GET IT
Times cited: 3
Charles L Christian: model physician scientist and mentor. Annals of the rheumatic diseases. 2021 Academic Article GET IT
Times cited: 3
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. Annals of the rheumatic diseases. 2021 Academic Article GET IT
Times cited: 24
Reply. Arthritis & rheumatology (Hoboken, N.J.). 2021 Letter GET IT
Expression of APOBEC family members as regulators of endogenous retroelements and malignant transformation in systemic autoimmunity. Clinical immunology (Orlando, Fla.). 2020 Academic Article GET IT
Times cited: 5
Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series. Arthritis & rheumatology (Hoboken, N.J.). 2020 Academic Article GET IT
Times cited: 82
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. Annals of the rheumatic diseases. 2020 Academic Article GET IT
Times cited: 40
Georgia Abortion Law and Our Commitment to Patients. Arthritis & rheumatology (Hoboken, N.J.). 2019 Letter GET IT
Times cited: 1
Reactivity of IgG With the p40 Protein Encoded by the Long Interspersed Nuclear Element 1 Retroelement: Comment on the Article by Carter et al. Arthritis & rheumatology (Hoboken, N.J.). 2019 Letter GET IT
Times cited: 3
Mitochondrial DNA promotes autoimmunity. Science (New York, N.Y.). 2019 Comment GET IT
Times cited: 12
Interferon target-gene expression and epigenomic signatures in health and disease. Nature immunology. 2019 Review GET IT
Times cited: 225
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, N.J.). 2019 Academic Article GET IT
Times cited: 521
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the rheumatic diseases. 2019 Review GET IT
Times cited: 511
TREX1 variants in Sjogren's syndrome related lymphomagenesis. Cytokine. 2019 Academic Article GET IT
Times cited: 15
Type I interferons in host defence and inflammatory diseases. Lupus science & medicine. 2019 Review GET IT
Times cited: 133
SLE: reconciling heterogeneity. Lupus science & medicine. 2019 Academic Article GET IT
Times cited: 82
Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018. Annals of the rheumatic diseases. 2019 Review GET IT
Times cited: 18
Type I Interferons in Autoimmune Disease. Annual review of pathology. 2018 Review GET IT
Times cited: 140
CD8 T cells and mTOR: new concepts and targets for systemic lupus erythematosus. Lancet (London, England). 2018 Comment GET IT
Times cited: 9
Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8. Science translational medicine. 2018 Academic Article GET IT
Times cited: 124
Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes. Journal of autoimmunity. 2017 Academic Article GET IT
Times cited: 56
The unmet need in rheumatology: Reports from the targeted therapies meeting 2017. Clinical immunology (Orlando, Fla.). 2017 Conference Paper GET IT
Times cited: 25
MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome. Scientific reports. 2017 Academic Article GET IT
Times cited: 26
Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Science signaling. 2016 Academic Article GET IT
Times cited: 111
Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease. Arthritis & rheumatology (Hoboken, N.J.). 2016 Academic Article GET IT
Times cited: 127
Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus. Clinical immunology (Orlando, Fla.). 2016 Academic Article GET IT
Times cited: 16
The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016. Clinical and experimental rheumatology. 2016 Conference Paper GET IT
Times cited: 23
Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory Myopathies. Scandinavian journal of immunology. 2016 Academic Article GET IT
Times cited: 22
Autoimmunity: Interferon α or β: which is the culprit in autoimmune disease?. Nature reviews. Rheumatology. 2016 Academic Article GET IT
Times cited: 25
Systemic lupus erythematosus. Nature reviews. Disease primers. 2016 Review GET IT
Times cited: 579
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial. Arthritis research & therapy. 2015 Academic Article GET IT
Times cited: 63
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis. Journal of autoimmunity. 2015 Academic Article GET IT
Times cited: 176
Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia. Arthritis & rheumatology (Hoboken, N.J.). 2015 Academic Article GET IT
Times cited: 55
Identification of Candidate Predictors of Lupus Flare. Transactions of the American Clinical and Climatological Association. 2015 Review GET IT
Times cited: 1
Targeting of type I interferon in systemic autoimmune diseases. Translational research : the journal of laboratory and clinical medicine. 2014 Review GET IT
Times cited: 80
Advances in understanding the role of type I interferons in systemic lupus erythematosus. Current opinion in rheumatology. 2014 Review GET IT
Times cited: 86
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial. Clinical and experimental rheumatology. 2014 Academic Article GET IT
Times cited: 24
Type I interferon in the pathogenesis of lupus. Journal of immunology (Baltimore, Md. : 1950). 2014 Review GET IT
Times cited: 351
Measuring interferon alpha and other cytokines in SLE. Methods in molecular biology (Clifton, N.J.). 2014 Academic Article GET IT
Times cited: 4
A surge in anti-dsDNA titer predicts a severe lupus flare within six months. Lupus. 2013 Academic Article GET IT
Times cited: 35
Increased serum type I interferon activity in organ-specific autoimmune disorders: clinical, imaging, and serological associations. Frontiers in immunology. 2013 Academic Article GET IT
Times cited: 348
Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis and rheumatism. 2013 Academic Article GET IT
Times cited: 114
Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits. Journal of neuroimmunology. 2012 Academic Article GET IT
Times cited: 34
Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis and rheumatism. 2012 Academic Article GET IT
Times cited: 74
Sarcoidosis triggered by interferon-Beta treatment of multiple sclerosis: a case report and focused literature review. Seminars in arthritis and rheumatism. 2012 Review GET IT
Times cited: 27
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Annals of the rheumatic diseases. 2011 Academic Article GET IT
Times cited: 120
Identification of a central role for complement in osteoarthritis. Nature medicine. 2011 Academic Article GET IT
Times cited: 415
Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis and rheumatism. 2011 Academic Article GET IT
Times cited: 99
Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-α and serologic autoimmunity in lupus patients. Journal of immunology (Baltimore, Md. : 1950). 2011 Academic Article GET IT
Times cited: 123
A 26-year-old white man with a systemic lupus erythematosus flare and acute multiorgan ischemia: Vasculitis or thrombosis?. Arthritis care & research. 2011 Conference Paper GET IT
Times cited: 2
Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. 2011 GET IT
Times cited: 83
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial. Annals of the rheumatic diseases. 2011 Academic Article GET IT
Times cited: 152
Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis and rheumatism. 2011 Academic Article GET IT
Times cited: 187
A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO molecular medicine. 2011 Academic Article GET IT
Times cited: 86
Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients. Arthritis and rheumatism. 2010 Academic Article GET IT
Times cited: 116
Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis research & therapy. 2010 Review GET IT
Times cited: 105
Activation of the type I interferon pathway in primary Sjogren's syndrome. Journal of autoimmunity. 2010 Review GET IT
Times cited: 133
Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis research & therapy. 2010 Academic Article GET IT
Times cited: 82
Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis and rheumatism. 2010 Academic Article GET IT
Times cited: 33
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain, behavior, and immunity. 2010 Academic Article GET IT
Times cited: 62
Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-beta/alpha ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort. Arthritis and rheumatism. 2010 Academic Article GET IT
Times cited: 62
Interferon-alpha: a therapeutic target in systemic lupus erythematosus. Rheumatic diseases clinics of North America. 2010 Academic Article GET IT
Times cited: 53
Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease. Autoimmunity. 2010 Review GET IT
Times cited: 64
Developments in the clinical understanding of lupus. Arthritis research & therapy. 2009 Review GET IT
Times cited: 35
Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus. Genes and immunity. 2009 Academic Article GET IT
Times cited: 92
Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis and cartilage. 2009 Academic Article GET IT
Times cited: 181
Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. Journal of immunology (Baltimore, Md. : 1950). 2009 Academic Article GET IT
Times cited: 206
Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. Journal of immunology (Baltimore, Md. : 1950). 2009 Academic Article GET IT
Times cited: 196
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis and rheumatism. 2009 Academic Article GET IT
Times cited: 81
Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults. Lupus. 2009 Academic Article GET IT
Times cited: 15
Interferon-induced versus chemokine transcripts as lupus biomarkers. Arthritis research & therapy. 2008 Editorial Article GET IT
Times cited: 9
Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?. Current opinion in rheumatology. 2008 Review GET IT
Times cited: 202
The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in patients with lupus. Arthritis and rheumatism. 2008 Academic Article GET IT
Times cited: 81
A bridge between interferon-alpha and tumor necrosis factor in lupus. The Journal of rheumatology. 2008 Editorial Article GET IT
Times cited: 17
Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis and rheumatism. 2008 Academic Article GET IT
Times cited: 226
Fast forward for systemic lupus erythematosus clinical trials. Nature clinical practice. Rheumatology. 2008 Editorial Article GET IT
Times cited: 1
Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade. Annals of the rheumatic diseases. 2008 Academic Article GET IT
Times cited: 23
Age- and sex-related patterns of serum interferon-alpha activity in lupus families. Arthritis and rheumatism. 2008 Academic Article GET IT
Times cited: 76
Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis. Current rheumatology reports. 2008 Academic Article GET IT
Times cited: 2
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Annals of the rheumatic diseases. 2008 Academic Article GET IT
Times cited: 196
Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus. Arthritis and rheumatism. 2008 Academic Article GET IT
Times cited: 71
Collaboration, genetic associations, and lupus erythematosus. The New England journal of medicine. 2008 Editorial Article GET IT
Times cited: 74
Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept. Arthritis and rheumatism. 2007 Academic Article GET IT
Times cited: 127
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus. Arthritis and rheumatism. 2007 Academic Article GET IT
Times cited: 153
Systemic lupus erythematosus predicts increased left ventricular mass. Circulation. 2007 Academic Article GET IT
Times cited: 66
Activation of type I interferon in systemic lupus erythematosus. Expert review of clinical immunology. 2007 Academic Article GET IT
Times cited: 16
High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes and immunity. 2007 Academic Article GET IT
Times cited: 348
Distinct inflammatory gene pathways induced by particles. Clinical orthopaedics and related research. 2007 Academic Article GET IT
Times cited: 20
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature immunology. 2007 Academic Article GET IT
Times cited: 1125
Mentors and heroes: the foundation and future of rheumatology. Arthritis and rheumatism. 2007 Conference Paper GET IT
Times cited: 2
Type I interferon in systemic lupus erythematosus. Current topics in microbiology and immunology. 2007 Review GET IT
Times cited: 96
Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis. Osteoarthritis and cartilage. 2006 Academic Article GET IT
Times cited: 250
Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis and rheumatism. 2006 Academic Article GET IT
Times cited: 106
Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. Journal of immunology (Baltimore, Md. : 1950). 2006 Academic Article GET IT
Times cited: 64
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis and rheumatism. 2006 Academic Article GET IT
Times cited: 260
Modification of accessory molecule signaling. Springer seminars in immunopathology. 2006 Review GET IT
Times cited: 21
Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. Journal of autoimmunity. 2006 Academic Article GET IT
Times cited: 114
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Annals of internal medicine. 2006 Academic Article GET IT
Times cited: 256
Soluble mediators as therapeutic targets in systemic lupus erythematosus: cytokines, immunoglobulin receptors, and the complement system. Rheumatic diseases clinics of North America. 2006 Review GET IT
Times cited: 15
The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheumatic diseases clinics of North America. 2006 Review GET IT
Times cited: 120
Early growth response-1 is required for CD154 transcription. Journal of immunology (Baltimore, Md. : 1950). 2006 Academic Article GET IT
Times cited: 26
Interferon pathway activation in systemic lupus erythematosus. Current rheumatology reports. 2005 Review GET IT
Times cited: 37
Arterial stiffness in chronic inflammatory diseases. Hypertension (Dallas, Tex. : 1979). 2005 Academic Article GET IT
Times cited: 270
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis and rheumatism. 2005 Academic Article GET IT
Times cited: 546
Academic rheumatology: not just a man's world. Arthritis and rheumatism. 2005 Comment GET IT
Times cited: 1
Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis and rheumatism. 2004 Academic Article GET IT
Times cited: 344
Interferon-alpha in systemic lupus erythematosus. Current opinion in rheumatology. 2004 Review GET IT
Times cited: 123
Costimulatory molecules and T-cell-B-cell interactions. Rheumatic diseases clinics of North America. 2004 Review GET IT
Times cited: 21
Measurement of cytokines in autoimmune disease. Methods in molecular medicine. 2004 Academic Article GET IT
Times cited: 11
Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions. Autoimmunity. 2004 Academic Article GET IT
Times cited: 12
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. The New England journal of medicine. 2003 Academic Article GET IT
Times cited: 1206
Microarray analysis of interferon-regulated genes in SLE. Autoimmunity. 2003 Review GET IT
Times cited: 234
Type I interferon and autoimmune disease. Autoimmunity. 2003 Review GET IT
Times cited: 13
Microarray analysis of gene expression in lupus. Arthritis research & therapy. 2003 Review GET IT
Times cited: 159
Interferon-alpha: a new target for therapy in systemic lupus erythematosus?. Arthritis and rheumatism. 2003 Editorial Article GET IT
Times cited: 85
Angiotropic large-cell lymphoma with striking blue plaques. Journal of the American Academy of Dermatology. 2003 Letter GET IT
Times cited: 3
Studies of autologous T cell activation in the Kunkel laboratory. Lupus. 2003 Review GET IT
Times cited: 4
T cell proliferation induced by autologous non-T cells is a response to apoptotic cells processed by dendritic cells. Journal of immunology (Baltimore, Md. : 1950). 2002 Academic Article GET IT
Times cited: 38
Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Human immunology. 2001 Academic Article GET IT
Times cited: 32
Regulation of CD40 ligand expression in systemic lupus erythematosus. Current opinion in rheumatology. 2001 Review GET IT
Times cited: 55
Segmental amplification of 11q23 region identified by fluorescence in situ hybridization in four patients with myeloid disorders: a review. Cancer genetics and cytogenetics. 2001 Review GET IT
Times cited: 19
Induction of Fas ligand-mediated apoptosis by interferon-alpha. Clinical immunology (Orlando, Fla.). 2000 Academic Article GET IT
Times cited: 59
Remission of juvenile rheumatoid arthritis after infection with parvovirus B19. 1999 GET IT
Times cited: 15
Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis and rheumatism. 1999 Academic Article GET IT
Times cited: 142
New pieces to the SLE cytokine puzzle. Clinical immunology (Orlando, Fla.). 1999 Editorial Article GET IT
Times cited: 22
Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood. 1998 Academic Article GET IT
Times cited: 68
Structural motifs in rheumatoid T-cell receptors. DNA and cell biology. 1998 Academic Article GET IT
Times cited: 5
Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. The Journal of clinical investigation. 1997 Academic Article GET IT
Times cited: 158
Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research. 1997 Academic Article GET IT
Times cited: 23
Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. Leukemia & lymphoma. 1996 Academic Article GET IT
Times cited: 12
Allelic variants of human TCR BV17S1 defined by restriction fragment length polymorphism, single strand conformation polymorphism, and amplification refractory mutation system analyses. Human immunology. 1996 Academic Article GET IT
Times cited: 3
CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells. Blood. 1996 Academic Article GET IT
Times cited: 76
Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. The Journal of clinical investigation. 1996 Academic Article GET IT
Times cited: 336
T helper cell-dependent, microbial superantigen-mediated B cell activation in vivo. Autoimmunity. 1996 Academic Article GET IT
Times cited: 21
CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. The Journal of experimental medicine. 1995 Academic Article GET IT
Times cited: 261
Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. Journal of leukocyte biology. 1995 Academic Article GET IT
Times cited: 208
Characterization of oligoclonal synovial T-cells in rheumatoid arthritis. Annals of the New York Academy of Sciences. 1995 Academic Article GET IT
Times cited: 3
A feasibility study for removing tissue contamination from porous implants. Biomedical instrumentation & technology. 1995 Academic Article GET IT
Times cited: 4
CDR3 sequence motifs shared by oligoclonal rheumatoid arthritis synovial T cells. Evidence for an antigen-driven response. 1994 GET IT
Times cited: 58
Increased frequency of V beta 17-positive T cells in patients with rheumatoid arthritis. Arthritis and rheumatism. 1994 Academic Article GET IT
Times cited: 48
Autoantigen-specific T cell proliferation induced by the ribosomal P2 protein in patients with systemic lupus erythematosus. The Journal of clinical investigation. 1994 Academic Article GET IT
Times cited: 46
Multiple myeloma after cardiac transplantation: an unusual form of posttransplant lymphoproliferative disorder. 1994 GET IT
Times cited: 26
Role of transforming growth factor beta (TGF beta) in systemic autoimmunity. Lupus. 1993 Review GET IT
Times cited: 19
Microbial superantigens as etiopathogenic agents in autoimmunity. Rheumatic diseases clinics of North America. 1993 Review GET IT
Times cited: 30
Human B cell differentiation induced by microbial superantigens: unselected peripheral blood lymphocytes secrete polyclonal immunoglobulin in response to Mycoplasma arthritidis mitogen. Autoimmunity. 1992 Academic Article GET IT
Times cited: 30
Microbial superantigens and autoimmune disease. Bulletin on the rheumatic diseases. 1992 Academic Article GET IT
Times cited: 2
Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cells. The Journal of experimental medicine. 1991 Academic Article GET IT
Times cited: 61
T helper cell-dependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. Journal of immunology (Baltimore, Md. : 1950). 1991 Academic Article GET IT
Times cited: 42
A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease. Arthritis and rheumatism. 1991 Review GET IT
Times cited: 119
Inhibition by anti-CD2 monoclonal antibodies of anti-CD3-induced T cell-dependent B cell activation. Cellular immunology. 1990 Academic Article GET IT
Times cited: 5
Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. The Journal of experimental medicine. 1990 Academic Article GET IT
Times cited: 58
Cognate T helper cell/B cell interaction in man. Research in immunology. 1990 Review GET IT
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cells. The Journal of clinical investigation. 1989 Academic Article GET IT
Times cited: 3
T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells. Clinical immunology and immunopathology. 1989 Academic Article GET IT
Times cited: 18
Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion. The Journal of clinical investigation. 1989 Academic Article GET IT
Times cited: 27
Human peripheral blood T helper cell-induced B cell activation results in B cell surface expression of the CD23 (BLAST-2) antigen. Cellular immunology. 1989 Academic Article GET IT
Times cited: 20
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. The Journal of clinical investigation. 1989 Academic Article GET IT
Times cited: 147
Interleukin 1 production during accessory cell-dependent mitogenesis of T lymphocytes. The Journal of experimental medicine. 1989 Academic Article GET IT
Times cited: 27
Amplification of altered self-reactive cytolytic T lymphocyte responses by cloned, allospecific human Th cells. The Journal of clinical investigation. 1988 Academic Article GET IT
Times cited: 1
Direct human T helper cell-induced B cell activation is not mediated by inositol lipid hydrolysis. Journal of immunology (Baltimore, Md. : 1950). 1988 Academic Article GET IT
Times cited: 13
Antigen-specific, MHC nonrestricted T helper cell-induced B cell activation. The Journal of experimental medicine. 1986 Academic Article GET IT
Times cited: 8
Direct T helper-B cell interactions induce an early B cell activation antigen. The Journal of experimental medicine. 1986 Academic Article GET IT
Times cited: 31
Human helper-T-cell function does not require T4 antigen expression. Cellular immunology. 1986 Academic Article GET IT
Times cited: 3
Anti-immunoglobulin stimulation of human B lymphocytes is inhibited by anti-class II major histocompatibility complex antibodies. Cellular immunology. 1985 Academic Article GET IT
Times cited: 14
Synergy between B cell differentiation factors and interleukin 2, using a monoclonal system. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 15
Purification and in vitro growth of human epidermal basal keratinocytes using a monoclonal antibody. The Journal of investigative dermatology. 1985 Academic Article GET IT
Times cited: 19
Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 109
Cloned allospecific human helper T cell lines induce an MHC-restricted proliferative response by resting B cells. Journal of immunology (Baltimore, Md. : 1950). 1985 Academic Article GET IT
Times cited: 11
Enhancement of the impaired autologous mixed leukocyte reaction in patients with systemic lupus erythematosus. The Journal of clinical investigation. 1985 Academic Article GET IT
Times cited: 13
Systemic lupus erythematosus with deficiency of the T4 epitope on T helper/inducer cells. 1985 GET IT
Times cited: 28
Activated B lymphocytes: stimulators of an augmented autologous mixed leukocyte reaction. Cellular immunology. 1985 Academic Article GET IT
Times cited: 20
An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells. Journal of immunology (Baltimore, Md. : 1950). 1984 Academic Article GET IT
Times cited: 35
Modulation of mononuclear phagocyte function by intravenous gamma-globulin. Journal of immunology (Baltimore, Md. : 1950). 1984 Academic Article GET IT
Times cited: 173
Human dendritic cells: major stimulators of the autologous and allogeneic mixed leucocyte reactions. Clinical and experimental immunology. 1982 Academic Article GET IT
Times cited: 131

more ...

less ...

Background

education and training

M.D., Cornell University Medical College 1978
B.A., Manhattanville College 1972

Contact

full name

Mary K Crow

primary email

mac2049@med.cornell.edu

VIVO Weill Cornell Medical College

Mary K Crow Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email